Nicolò Bizzarri Selected Research

L19-IL2 immunocytokine

8/2019

L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicolò Bizzarri Research Topics

Disease

16	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2022 - 01/2016
11	Neoplasms (Cancer) 09/2022 - 01/2018
6	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2018
3	Adenocarcinoma 01/2022 - 12/2020
3	Ovarian Epithelial Carcinoma 01/2022 - 10/2019
3	Carcinoma (Carcinomatosis) 07/2021 - 08/2019
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2020
2	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 01/2022
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 12/2020
2	Leiomyoma (Uterine Fibroids) 01/2022 - 06/2015
2	Endometriosis 06/2015 - 09/2014
1	Rectal Neoplasms (Rectal Cancer) 09/2022
1	Margins of Excision 01/2022
1	Pelvic Pain 01/2022
1	COVID-19 01/2021
1	Adenosquamous Carcinoma 12/2020
1	Pancreatic Fistula (Pancreatic Fistulas) 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 04/2019
1	Endometrial Stromal Sarcoma 04/2019
1	Leiomyosarcoma 01/2019
1	Paraganglioma (Paragangliomas) 09/2018
1	Disease Progression 09/2018
1	Myoma 09/2015
1	Atrial Fibrillation 12/2014

Drug/Important Bio-Agent (IBA)

4	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2022 - 01/2018
2	Nucleic AcidsIBA 12/2020 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2018 - 06/2015
2	ulipristal acetate FDA Link 09/2015 - 06/2015
2	dienogest FDA Link 06/2015 - 09/2014
1	PlatinumIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2020
1	Hematoxylin (Haematoxylon)IBA 12/2020
1	Keratins (Keratin)IBA 01/2020
1	L19-IL2 immunocytokineIBA 08/2019
1	Interleukin-2 (IL2)IBA 08/2019
1	Proteins (Proteins, Gene)FDA Link 08/2019
1	Protein Isoforms (Isoforms)IBA 08/2019
1	Syndecan-1 (Syndecan 1)IBA 08/2019
1	Fibronectins (Fibronectin)IBA 08/2019
1	Sunitinib (Sutent)FDA Link 09/2018
1	Bevacizumab (Avastin)FDA Link 01/2016
1	Monoclonal AntibodiesIBA 01/2016
1	Triptorelin Pamoate (Trelstar)FDA Link 09/2015
1	Letrozole (Femara)FDA LinkGeneric 09/2015
1	Progesterone FDA LinkGeneric 06/2015
1	Dronedarone FDA Link 12/2014
1	Progestins (Progestagens)IBA 09/2014
1	Nandrolone (Nortestosterone)IBA 09/2014

Therapy/Procedure

8	Hysterectomy 01/2022 - 01/2018
6	Lymph Node Excision (Lymph Node Dissection) 10/2021 - 04/2019
4	Cytoreduction Surgical Procedures 01/2022 - 01/2018
3	Radiotherapy 09/2022 - 09/2018
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
3	Neoadjuvant Therapy 01/2022 - 09/2018
3	Minimally Invasive Surgical Procedures 03/2021 - 06/2020
2	Chemoradiotherapy 01/2022 - 10/2021
2	Pelvic Exenteration 01/2021 - 11/2019
2	Ovariectomy (Oophorectomy) 01/2021 - 04/2019
2	Splenectomy 01/2020 - 01/2018
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022
1	Operative Surgical Procedures 01/2022
1	Aftercare (After-Treatment) 01/2022
1	Salpingo-oophorectomy 01/2022
1	Conservative Treatment 01/2021
1	Personal Protective Equipment 01/2021
1	Trachelectomy 01/2021
1	Urinary Diversion (Ileal Conduit) 01/2021
1	Palliative Care (Palliative Therapy) 01/2021
1	Pancreatectomy 01/2020
1	Length of Stay 01/2020
1	Therapeutics 08/2019
1	Cholecystectomy 01/2018
1	Laparotomy 01/2018